Muscular Dystrophy Clinical Trials in Little Rock, Arkansas
12 recruitingLittle Rock, Arkansas
Showing 1–12 of 12 trials
Recruiting
Phase 1
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy
Insmed Gene Therapy LLC12 enrolled10 locationsNCT06817382
Recruiting
Phase 3
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Duchenne Muscular Dystrophy
Solid Biosciences Inc.80 enrolled5 locationsNCT07160634
Recruiting
Duchenne Electronic Health Record Study
Becker muscular dystrophyDuchenne Muscular Dystrophy (DMD)Dystrophinopathy+1 more
The Duchenne Registry2,500 enrolled10 locationsNCT07609394
Recruiting
Phase 1Phase 2
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Duchenne Muscular Dystrophy
Solid Biosciences Inc.60 enrolled15 locationsNCT06138639
Recruiting
Phase 1Phase 2
PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Precision BioSciences, Inc.18 enrolled1 locationNCT07429240
Recruiting
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Duchene Muscular Dystrophy
ITF Therapeutics LLC300 enrolled7 locationsNCT07127978
Recruiting
Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc.83 enrolled7 locationsNCT04626674
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy
Hoffmann-La Roche50 enrolled25 locationsNCT06450639
Recruiting
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Duchenne Muscular Dystrophy
Catalyst Pharmaceuticals, Inc.250 enrolled27 locationsNCT06564974
Recruiting
Phase 2Phase 3
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy
REGENXBIO Inc.65 enrolled17 locationsNCT05693142
Recruiting
Phase 1Phase 2
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Duchenne Muscular Dystrophy
Wave Life Sciences USA, Inc.26 enrolled5 locationsNCT04906460
Recruiting
CureDuchenne Link®: A Resource for Research
Becker muscular dystrophyDuchenne Muscular Dystrophy
CureDuchenne5,000 enrolled10 locationsNCT04972604